A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small C

ClinicalKey

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

Prospective study of 197 cancer patients reports 84.4% clinical benefit rate with ivermectin and mebendazole combination

This prospective observational cohort study analyzed 197 cancer patients prescribed a combination of ivermectin and mebendazole off-label vi

PD-L1 High Advanced NSCLC: Is Immunotherapy Alone Always Enough?

Lung Cancer Patients on Drug From China’s Akeso Lived Longer

Dose-reduced thoracic radiotherapy shows promise for older and frail stage III NSCLC patients in randomized trial

This randomized open-label cohort trial by Wei-Xiang Qi and colleagues investigates whether dose-reduced thoracic radiotherapy can mitigate